Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-128524
Filing Date
2020-11-23
Accepted
2020-11-23 17:11:46
Documents
1
Period of Report
2020-11-20

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 6712
  Complete submission text file 0001104659-20-128524.txt   8115
Mailing Address C/O WARNER CHILCOTT HOLDINGS CO., LTD. 100 ENTERPRISE DRIVE ROCKAWAY NJ 07866
Business Address
Burgstahler David F (Reporting) CIK: 0001374179 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38709 | Film No.: 201338868

Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Issuer) CIK: 0001739426 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations